Mark A. Fiala

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 28 papers. Top paper: “Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19”.

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

JAMA Oncology(2022)10.1001/jamaoncol.2022.5357

N/A

1.5DataRank · unranked

63 citations

Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih–Yuan Hsu +95 more

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

Blood Advances(2020)10.1182/bloodadvances.2019000491

N/A

1.1DataRank · unranked

31 citations

Niels Weinhold, Gregory Song, Kristin A. Rand, David Van Den Berg, Amie E. Hwang +65 more

A pilot study of adherence to lenalidomide among older patients with multiple myeloma

Journal of Geriatric Oncology(2023)10.1016/j.jgo.2023.101560

N/A

0.165DataRank · unranked

2 citations

Mark A. Fiala, Kah Poh Loh, Theresa Cordner, Hira Mian, Tanya M. Wildes +1 more

Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.09.010

N/A

0DataRank · unranked

19 citations

Mark A. Fiala, Tanya M. Wildes, Hira Mian

Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatment

Journal of Geriatric Oncology(2020)10.1016/j.jgo.2020.05.004

N/A

0DataRank · unranked

15 citations

Gregory R. Pond, Sascha A. Tuchman, Mark A. Fiala, Tanya M. Wildes, Hira Mian

The characteristics, treatment patterns, and outcomes of older adults aged 80 and over with multiple myeloma

Journal of Geriatric Oncology(2020)10.1016/j.jgo.2020.03.005

N/A

0DataRank · unranked

19 citations

Nicole Foley, Sonja Zweegman, Ravi Vij, Tanya M. Wildes, Mark A. Fiala

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2839

N/A

0DataRank · unranked

27 citations

Michael J. Scott, John S. Allen, Xiaoxia Yang, Grace Cui, Dipanjan Pan +12 more

Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors

Blood Advances(2021)10.1182/bloodadvances.2021005149

N/A

0DataRank · unranked

32 citations

Min Shi, Mark A. Fiala, Feng Gao, Michael P. Rettig, Geoffrey L. Uy +6 more

A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma

Scientific Reports(2021)10.1038/s41598-021-98760-9

N/A

0DataRank · unranked

16 citations

Amanda Jeske, Pilar de la Puente, Jennifer Sun, Mark A. Fiala, Feda Azab +6 more

A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.02.027

N/A

0DataRank · unranked

15 citations

Tyler McKinnish, Mark A. Fiala, Abigail Zamorano, Lindsay M. Kuroki, Katherine C. Fuh +7 more

Bortezomib in first-line therapy is associated with falls in older adults with multiple myeloma

Journal of Geriatric Oncology(2021)10.1016/j.jgo.2021.02.009

N/A

0DataRank · unranked

10 citations

Mark A. Fiala, Tanya M. Wildes, Kelly L. Schoenbeck

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.4304

N/A

0DataRank · unranked

72 citations

Sonya Reid, Benjamin French, Cassandra Hennessy, Clara Hwang, Na Tosha Gatson +95 more

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

Scientific Reports(2022)10.1038/s41598-021-03748-0

N/A

0DataRank · unranked

23 citations

Chantiya Chanswangphuwana, Nicholas S. Cho, Francesca Fontana, Dolonchampa Maji, Julie Ritchey +10 more

Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma

Leukemia(2022)10.1038/s41375-022-01691-1

N/A

0DataRank · unranked

15 citations

Thomas G. Martin, Nitya Nathwani, Mark A. Fiala, Michael P. Rettig, Feng Gao +10 more

Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.42046

N/A

0DataRank · unranked

11 citations

Tianyi Sun, David D. Chism, Narjust Duma, Julie Fu, Na Tosha Gatson +87 more

A prospective study of adherence to lenalidomide for multiple myeloma using Medication Event Monitoring System (MEMS) caps

medRxiv(2022)10.1101/2022.05.30.22275780

N/A

0DataRank · unranked

0 citations

Mark A. Fiala, Kah Poh Loh, Theresa Cordner, Hira Mian, Tanya M. Wildes +1 more

Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.09.014

N/A

0DataRank · unranked

1 citations

Mark A. Fiala, Marie Kirchmeyer, Jeffrey King, Feng Gao, Mark A. Schroeder +5 more

Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.08.017

N/A

0DataRank · unranked

2 citations

Jaebok Choi, Matthew Cooper, Jeffrey King, Mark A. Fiala, Jingxia Liu +13 more

From criteria to clinic: How updated SLiM CRAB criteria influence multiple myeloma diagnostic activity.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.7556

N/A

0DataRank · unranked

5 citations

Mei Wang, Yi-Hsuan Shih, John H. Huber, Mark A. Fiala, Rong Wang +6 more

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

UNC Libraries(2024)10.17615/ct6n-5k64

N/A

0DataRank · unranked

0 citations

David V. Conti, J Mehta, Thomas G. Martin, Kenneth C. Anderson, Song, G.C. +65 more

Treatment Access among Younger Medicaid Beneficiaries with Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2024)10.1016/j.clml.2024.07.017

N/A

0DataRank · unranked

0 citations

Mengmeng Ji, Yi-Hsuan Shih, John H. Huber, Mei Wang, Kimberly J. Johnson +6 more

Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma

The Journal of Immunology(2025)10.1093/jimmun/vkae004

N/A

0DataRank · unranked

5 citations

Nancy D. Marín, Sadia Afrin, Pamela Wong, Jennifer Tran, Miriam T. Jacobs +23 more

Ablation of CD38 in multiple myeloma cells leads to an aggressive phenotype in a mouse xenograft model

Blood Advances(2025)10.1182/bloodadvances.2025017296

N/A

0DataRank · unranked

1 citations

Alexander Zheleznyak, Erin N. Teubner, Julie L. Prior, Brad Manion, Zhenghan Jing +10 more

Characterization of Germline Variants in Multiple Myeloma

Blood(2018)10.1182/blood-2018-99-118673

N/A

0DataRank · unranked

0 citations

Qingsong Gao, Kuan-lin Huang, Steven M. Foltz, Justin King, Mark A. Fiala +7 more

Investigation of lncRNA expression in newly diagnosed multiple myeloma reveals a LINC01432-CELF2 axis as an inhibitor of apoptosis

Oncogenesis(2025)10.1038/s41389-025-00579-w

N/A

0DataRank · unranked

1 citations

Prasanth Thunuguntla, Dhanusha Duraiyan, Alani Perkin, Katelyn Bagwill, Savannah Gonzales +19 more

Racial Disparities in the Utilization of Novel Agents for Frontline Treatment of Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.04.018

N/A

0DataRank · unranked

22 citations

Tanya M. Wildes, Ravi Vij, Mark A. Fiala

Statins Reduce Mortality in Multiple Myeloma: A Population-Based US Study

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.07.003

N/A

0DataRank · unranked

19 citations

Mark A. Fiala, Brian F. Gage, Tanya M. Wildes, Kristen M. Sanfilippo, Amber Afzal